Telix Pharmaceuticals Limited TLPPF
Set alert
8.95 USD +0.15 +1.70%
At close · Oct 30
8.80 Day range 8.80
5.91 52-week range 13.00
- YTD
- +15.63%
- 1 year
- -18.64%
- Open
- 8.80
- Prev close
- 8.80
- Mkt cap
- 3.03B
- Vol
- 400
- Avg vol
- 1.84K
- EPS
- 0.10
- P/E
- 89.50
More statistics
- Low
- 8.80
- High
- 8.80
- Earnings
- Aug 20, 2026
YTD chart
Events in this range
- Feb 19, 2026Earnings: -0.0116; estimate 0.03277; surprise -135.4%
- Aug 20, 2026Earnings: —; estimate 0.04336; surprise —%
Signals (44)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| RSI: Oversold | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 8, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 7, 2026 | 6 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 9 months ago |
| RSI: Oversold | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 10 months ago |
Next earnings
Aug 20, 2026
Expected Aug 20, 2026. Consensus EPS estimate 0.04336.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 20, 2026 | Jun 30, 2026 | 0.04336 | — | — | — |
| Feb 19, 2026 | Dec 31, 2025 | 0.03277 | -0.0116 | -0.04 | -135.40% |
| Aug 20, 2025 | Jun 30, 2025 | 0.1335 | -0.00677 | -0.14 | -105.07% |
| Feb 20, 2025 | Dec 31, 2024 | 0.09047 | 0.06856 | -0.02 | -24.22% |
| Aug 22, 2024 | Jun 30, 2024 | 0.09011 | 0.0222 | -0.07 | -75.36% |
| May 21, 2024 | Dec 31, 2023 | — | 0.04107 | — | — |
News
- Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion
- Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady
- Telix Pharmaceuticals: Solid Q1 As Pipeline And PSMA Franchise Drive Outlook
- Why Is Telix Pharma Stock Soaring Tuesday?
- Telix Pharmaceuticals (OTCMKTS:TLPPF) Shares Down 5.3% – Time to Sell?
- Telix Pharmaceuticals Limited (TLX) Discusses Revenue Growth, Prostate Cancer Imaging Portfolio, and Expansion into Brain and Kidney Cancer Transcript
- Telix Pharmaceuticals Limited (TLX) Discusses ProstACT Global Phase 3 Study Part 1 Results and Safety Profile Transcript
- Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
- Telix Pharmaceuticals: Scope Of Company Beyond Radio Antibody-Drug Conjugate TLX591-Tx
- Telix Pharmaceuticals Limited (TLX) Q4 2025 Earnings Call Transcript
Your note
Sign in to keep a note on TLPPF — it syncs with the Stock Master app.